These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32464432)

  • 1. Age-dependent effect of APOE and polygenic component on Alzheimer's disease.
    Bellou E; Baker E; Leonenko G; Bracher-Smith M; Daunt P; Menzies G; Williams J; Escott-Price V;
    Neurobiol Aging; 2020 Sep; 93():69-77. PubMed ID: 32464432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considering the APOE locus in Alzheimer's disease polygenic scores in the Health and Retirement Study: a longitudinal panel study.
    Ware EB; Faul JD; Mitchell CM; Bakulski KM
    BMC Med Genomics; 2020 Nov; 13(1):164. PubMed ID: 33143703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.
    Desikan RS; Fan CC; Wang Y; Schork AJ; Cabral HJ; Cupples LA; Thompson WK; Besser L; Kukull WA; Holland D; Chen CH; Brewer JB; Karow DS; Kauppi K; Witoelar A; Karch CM; Bonham LW; Yokoyama JS; Rosen HJ; Miller BL; Dillon WP; Wilson DM; Hess CP; Pericak-Vance M; Haines JL; Farrer LA; Mayeux R; Hardy J; Goate AM; Hyman BT; Schellenberg GD; McEvoy LK; Andreassen OA; Dale AM
    PLoS Med; 2017 Mar; 14(3):e1002258. PubMed ID: 28323831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polygenic Scores of Alzheimer's Disease Risk Genes Add Only Modestly to APOE in Explaining Variation in Amyloid PET Burden.
    Ramanan VK; Heckman MG; Przybelski SA; Lesnick TG; Lowe VJ; Graff-Radford J; Mielke M; Jack CR; Knopman DS; Petersen RC; Ross OA; Vemuri P;
    J Alzheimers Dis; 2022; 88(4):1615-1625. PubMed ID: 35811524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic risk for alzheimer disease is distinct from genetic risk for amyloid deposition.
    Leonenko G; Shoai M; Bellou E; Sims R; Williams J; Hardy J; Escott-Price V;
    Ann Neurol; 2019 Sep; 86(3):427-435. PubMed ID: 31199530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common polygenic variation enhances risk prediction for Alzheimer's disease.
    Escott-Price V; Sims R; Bannister C; Harold D; Vronskaya M; Majounie E; Badarinarayan N; ; ; Morgan K; Passmore P; Holmes C; Powell J; Brayne C; Gill M; Mead S; Goate A; Cruchaga C; Lambert JC; van Duijn C; Maier W; Ramirez A; Holmans P; Jones L; Hardy J; Seshadri S; Schellenberg GD; Amouyel P; Williams J
    Brain; 2015 Dec; 138(Pt 12):3673-84. PubMed ID: 26490334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated analysis of direct and proxy genome wide association studies highlights polygenicity of Alzheimer's disease outside of the APOE region.
    de la Fuente J; Grotzinger AD; Marioni RE; Nivard MG; Tucker-Drob EM
    PLoS Genet; 2022 Jun; 18(6):e1010208. PubMed ID: 35658006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polygenic risk score in postmortem diagnosed sporadic early-onset Alzheimer's disease.
    Chaudhury S; Patel T; Barber IS; Guetta-Baranes T; Brookes KJ; Chappell S; Turton J; Guerreiro R; Bras J; Hernandez D; Singleton A; Hardy J; Mann D; ; Morgan K
    Neurobiol Aging; 2018 Feb; 62():244.e1-244.e8. PubMed ID: 29103623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polygenic Risk Scoring is an Effective Approach to Predict Those Individuals Most Likely to Decline Cognitively Due to Alzheimer's Disease.
    Daunt P; Ballard CG; Creese B; Davidson G; Hardy J; Oshota O; Pither RJ; Gibson AM
    J Prev Alzheimers Dis; 2021; 8(1):78-83. PubMed ID: 33336228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Greater effect of polygenic risk score for Alzheimer's disease among younger cases who are apolipoprotein E-ε4 carriers.
    Fulton-Howard B; Goate AM; Adelson RP; Koppel J; Gordon ML; ; Barzilai N; Atzmon G; Davies P; Freudenberg-Hua Y
    Neurobiol Aging; 2021 Mar; 99():101.e1-101.e9. PubMed ID: 33164815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Stratification to Identify Risk Groups for Alzheimer's Disease.
    Marioni RE; Campbell A; Hagenaars SP; Nagy R; Amador C; Hayward C; Porteous DJ; Visscher PM; Deary IJ
    J Alzheimers Dis; 2017; 57(1):275-283. PubMed ID: 28222519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing Genetic Overlap and Causality Between Blood Plasma Proteins and Alzheimer's Disease.
    Handy A; Lord J; Green R; Xu J; Aarsland D; Velayudhan L; Hye A; Dobson R; Proitsi P; ;
    J Alzheimers Dis; 2021; 83(4):1825-1839. PubMed ID: 34459398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the CD2AP locus with cognitive functioning among middle-aged individuals with a family history of Alzheimer's disease.
    Manzali SB; Ravona-Springer R; Alkelai A; Yu E; Gan-Or Z; Ganmore I; Heymann A; Beeri MS; Greenbaum L
    Neurobiol Aging; 2021 May; 101():50-56. PubMed ID: 33578194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Contribution of Genetic Factors to Cognitive Impairment and Dementia: Apolipoprotein E Gene, Gene Interactions, and Polygenic Risk.
    Fan J; Tao W; Li X; Li H; Zhang J; Wei D; Chen Y; Zhang Z
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30866553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polygenic risk and hazard scores for Alzheimer's disease prediction.
    Leonenko G; Sims R; Shoai M; Frizzati A; Bossù P; Spalletta G; Fox NC; Williams J; ; Hardy J; Escott-Price V
    Ann Clin Transl Neurol; 2019 Mar; 6(3):456-465. PubMed ID: 30911569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Alzheimer's Disease Genetic Risk Score Predicts Longitudinal Thinning of Hippocampal Complex Subregions in Healthy Older Adults.
    Harrison TM; Mahmood Z; Lau EP; Karacozoff AM; Burggren AC; Small GW; Bookheimer SY
    eNeuro; 2016; 3(3):. PubMed ID: 27482534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polygenic risk of Alzheimer's disease in the Faroe Islands.
    Johansen M; Joensen S; Restorff M; Stórá T; Christy D; Gustavsson EK; Bian J; Guo Y; Farrer MJ; Petersen MS
    Eur J Neurol; 2022 Aug; 29(8):2192-2200. PubMed ID: 35384166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the presence of shared genetic architecture between Alzheimer's disease and major depressive disorder using genome-wide association data.
    Gibson J; Russ TC; Adams MJ; Clarke TK; Howard DM; Hall LS; Fernandez-Pujals AM; Wigmore EM; Hayward C; Davies G; Murray AD; Smith BH; Porteous DJ; Deary IJ; McIntosh AM
    Transl Psychiatry; 2017 Apr; 7(4):e1094. PubMed ID: 28418403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Factors Affecting Late-Onset Alzheimer's Disease Susceptibility.
    Rezazadeh M; Khorrami A; Yeghaneh T; Talebi M; Kiani SJ; Heshmati Y; Gharesouran J
    Neuromolecular Med; 2016 Mar; 18(1):37-49. PubMed ID: 26553058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.